pinatuzumab vedotin pinatuzumab vedotin pinatuzumab vedotin (inn; development codes dcdt2980s and fcu2703) is a monoclonal antibody designed for the treatment of b-cell malignancies. pinatuzumab vedotinmonoclonal antibodytype?sourcehumanized (from mouse)targetcd22clinical dataother namesdcdt2980s, fcu2703atc codenoneidentifierscas number1313706-14-7chemspidernoneunii6ka1906blcchemical and physical dataformulac6748h10377n1773o2083s44molar mass151081.21 g·mol−1 this drug was developed by genentech/roche.